COMBINED MODALITY TREATMENT WITH INTENSIFIED CHEMOTHERAPY AND DOSE-REDUCED INVOLVED FIELD RADIOTHERAPY IN PATIENTS WITH EARLY UNFAVOURABLE HODGKIN LYMPHOMA (HL): FINAL ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG) HD11 TRIAL

被引：0
|
作者：
Engert, A.
Borchmann, P.
Diehl, V. [1 ]
Goergen, H. [1 ]
Mueller, H. [1 ]
Mueller, R.
Eich, H.
Mueller-Hermelink, H. [2 ]
Herrmann, R. [3 ]
Markova, J. [4 ]
Ho, A. [5 ]
Hiddemann, W. [6 ]
Doerken, B. [7 ]
Greil, R. [8 ]
机构：
[1] Univ Hosp Cologne, CHSG, Cologne, Germany
[2] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany
[3] Kantonsspital Basel, Basel, Switzerland
[4] Univ Hosp Prague, Prague, Czech Republic
[5] Heidelberg Univ, Med Clin V, Heidelberg, Germany
[6] Univ Hosp Grosshadern, Munich, Germany
[7] Charite, D-13353 Berlin, Germany
[8] Salzburg Univ, A-5020 Salzburg, Austria
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0410
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [31] Dose-Intensification in Early Unfavorable Hodgkin Lymphoma: Long-Term Follow up of the German Hodgkin Study Group (GHSG) HD14 Trial
    Gillessen, Sarah
    Plutschow, Annette
    Fuchs, Michael
    Markova, Jana
    Greil, Richard
    Topp, Max S.
    Meissner, Julia
    Zijlstra, Josee M.
    Eichenauer, Dennis A.
    Diehl, Volker
    Borchmann, Peter
    Engert, Andreas
    von Tresckow, Bastian
    BLOOD, 2019, 134
  • [32] BEACOPP chemotherapy with dose escalation in advanced Hodgkin's disease: Final analysis of the German Hodgkin lymphoma study group HD9 randomized trial.
    Diehl, V
    Franklin, J
    Paulus, U
    Engert, A
    Wolf, J
    Hasenclever, D
    Duehmke, E
    Georgii, A
    Mueller-Hermelink, HK
    Loeffler, M
    BLOOD, 2001, 98 (11) : 769A - 769A
  • [33] GONADAL FUNCTION IN WOMEN AFTER TREATMENT OF EARLY UNFAVOURABLE HODGKIN LYMPHOMA (HL). FIRST RESULTS OF THE FERTILITY RESEARCH PROJECT WITHIN THE 5TH TRIAL GENERATION, GERMAN HODGKIN STUDY GROUP (GHSG)
    Behringer, K.
    Mueller, H.
    Goergen, H.
    Eibl, A.
    Rosenbrock, J.
    Halbsguth, T.
    Diehl, V.
    Engert, A.
    Borchmann, P.
    ANNALS OF ONCOLOGY, 2011, 22 : 140 - 140
  • [34] Dose-Intensification in Early Unfavorable Hodgkin Lymphoma: Long-Term Follow-Up of the German Hodgkin Study Group (GHSG) HD14 Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 13 - 14
  • [35] Feasibility and Efficacy of ABVD In Elderly Hodgkin Lymphoma Patients: Analysis of Two Randomized Prospective Multicenter Trials of the German Hodgkin Study Group (HD10 and HD11)
    Boll, Boris
    Gorgen, Helen
    Fuchs, Michael
    von Tresckow, Bastian
    Engert, Andreas
    Borchmann, Peter
    BLOOD, 2010, 116 (21) : 186 - 187
  • [36] Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials
    Boell, Boris
    Goergen, Helen
    Behringer, Karolin
    Broeckelmann, Paul J.
    Hitz, Felicitas
    Kerkhoff, Andrea
    Greil, Richard
    von Tresckow, Bastian
    Eichenauer, Dennis A.
    Buerkle, Carolin
    Borchmann, Sven
    Fuchs, Michael
    Diehl, Volker
    Engert, Andreas
    Borchmann, Peter
    BLOOD, 2016, 127 (18) : 2189 - 2192
  • [37] Dose-Intensification in early unfavorable Hodgkin Lymphoma: Long-Term Follow up of the randomized German Hodgkin Study Group (GHSG) HD14 trial
    Gillessen, S.
    Pluetschow, A.
    Fuchs, M.
    Markova, J.
    Greil, R.
    Topp, M.
    Meissner, J.
    Zijlstra, J.
    Eichenauer, D.
    Broeckelmann, P.
    Diehl, V.
    Borchmann, P.
    Engert, A.
    von Tresckow, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 88 - 89
  • [38] FEASIBILITY AND EFFICACY OF ABVD IN ELDERLY HODGKIN LYMPHOMA PATIENTS: ANALYSIS OF TWO RANDOMIZED PROSPECTIVE MULTICENTER TRIALS OF THE GERMAN HODGKIN STUDY GROUP (HD10 AND HD11)
    Boell, B.
    Goergen, H.
    Fuchs, M.
    von Tresckow, B.
    Engert, A.
    Borchmann, P.
    HAEMATOLOGICA, 2010, 95 : S39 - S39
  • [39] Two cycles ABVD plus extended field radiotherapy is superior to radiotherapy alone in early stage Hodgkin's disease: Results of the German Hodgkin's Lymphoma Study Group (GHSG) trial HD7.
    Sieber, M
    Franklin, J
    Tesch, H
    Rueffer, U
    Brillant, C
    Reineke, T
    Herrmann, R
    Boissevain, F
    Franke, A
    Pfreundschuh, M
    Hossfeld, DK
    Wingbermuehle, K
    Josting, A
    Wolf, J
    Paulus, U
    Mueller, RP
    Duehmke, E
    Engert, A
    Diehl, V
    BLOOD, 2002, 100 (11) : 93A - 93A
  • [40] LONG-TERM FOLLOW-UP OF CONTEMPORARY TREATMENT IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA: UPDATED ANALYSES OF THE GERMAN HODGKIN STUDY GROUP HD8 AND HD11 TRIAL
    Sasse, S.
    Broeckelmann, P. J.
    Goergen, H.
    Pluetschow, A.
    Mueller, H.
    Kreissl, S.
    Buerkle, C.
    Borchmann, S.
    Fuchs, M.
    Borchmann, P.
    Engert, A.
    HAEMATOLOGICA, 2016, 101 : 13 - 14
12345